In order to explore whether elevated CHAF1A expression detected in breast cancer patients’ samples could be used to predict the sensitivity of the patients to therapeutic treatment, the correlations between the oncolytic response of patients and elevated CHAF1A expression were determined in Kaplan-Meier plotter (Győrffy, 2021). Here, CHAF1A is linked to breast cancer.